CV-LC-03 · standards
Runs the other way: the Canadian licence is the EVIDENCE, not the rule breached. Health Canada authorised the wording and the brand did nothing wrong, so this is written as a warning that the two markets diverge and never as an accusation.
Found on 1 of the 1,524 best-selling listings we have ruled, 1 time in total. That is 1 live product page carrying this wording today.
“the criteria by which FDA determines that a statement is a disease claim rather than a structure/function claim”
Source checked 2026-08-18.
FDCA s.201(g)(1)(B), 21 U.S.C. 321(g)(1)(B)
“definition of 'drug': articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease”
Source checked 2026-08-18.
Natural Health Products Regulations, SOR/2003-196, s.14(1)(h)
“the licence itself sets out the recommended use or purpose that is AUTHORIZED for the product; this is the text the LNHPD publishes and the text marketing is measured against”
Source checked 2026-08-18.
An interpretation. We applied a published legal test to the published copy and reached a conclusion. Reasonable reviewers applying the same test can disagree at the margin; this is our reviewer's professional opinion, and the test is cited so you can check the reasoning.
Claims Verified, standard CV-LC-03 "Canadian-licensed wording that is a US disease claim", standards v1.3.1, retrieved 16 September 2026, https://claimsverified.org/standards/CV-LC-03/
Or put it in your own policy
Marketing copy must not use "Canadian-licensed wording that is a US disease claim" or equivalent wording. See Claims Verified standard CV-LC-03 (standards v1.3.1): https://claimsverified.org/standards/CV-LC-03/
Cite it freely with attribution and the version. The whole register is machine-readable at /standards/registry.json. Rulings are our published professional opinion, not legal advice.
All 98 standards and the 98 in force · Check a listing against them free